JNK India Limited — Others, 30-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

JNK India Limited has announced a review confirming no deviation in the use of Rs 300 Cr raised via its IPO, with funds fully utilized for working capital and general corporate purposes. The Audit Committee verified the proper deployment without any remarks, and CRISIL Ratings Limited continues as the monitoring agency. This disciplined fund usage underscores the company’s operational stability and provides confidence to shareholders on effective financial management.